Correction highlights advances in Sinomenine formulations for rheumatoid arthritis, suggesting new administration routes.
Correction on: Wang W, Wang Z, Ling A, Zhang C, Lv M, Huang L and Niu Y (2025) Research progress in treatment of rheumatoid arthritis with Sinomenine and related formulations based on different administration routes. Front. Pharmacol. 16:1613679. doi: 10.3389/fphar.2025.1613679. Error in figure/table Figure/table caption There was a mistake in the caption of figure [2] as published. [The caption of FIGURE 2 was displayed as Structural diagram, physical appearance evaluation and SEM images of the surface of the SIN-HCl (A,C,E) common and (B,D,F) enteric-coated sustained-release pellets. Reproduced with permission from Wu et al., AAPS PharmSciTech; published by Springer Nature Link, 2024.]. The corrected caption of figure [2] appears below. "[Schematic diagram illustrating the mechanism of nanocomposite hydrogel in repairing joint inflammation (1: The application of drugs to target cells for synergistic effects; 2: The simulation of joint environment to reduce friction; 3: The loading of seed cells onto the nanofiber scaffold to induce chondrocyte differentiation).]" The original version of this article has been updated.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: